论文部分内容阅读
目的研究纳洛酮联合血必净对感染性休克患者的临床治疗效果,为临床治疗感染性休克提供理论指导依据。方法选取2013年2月-2015年2月在医院接受治疗的90例感染性休克患者作为研究对象,并将其随机分为观察组与对照组,每组各45例;对照组患者使用常规感染性休克治疗方法,观察组患者在对照组治疗的基础上使用纳洛酮联合血必净对其实施治疗,比较两组患者治疗疗效,数据采用SPSS 16.0软件进行统计分析。结果观察组45例患者中治愈42例,总有效率93.3%,对照组45例患者中治愈32例,总有效率71.1%,观察组要明显优于对照组。结论使用纳洛酮联合血必净可以有效地改善感染性休克患者的病情,其治疗效果显著,可以有效提高感染性休克患者的生存率。
Objective To study the clinical effect of naloxone combined with Xuebijing in septic shock patients and to provide theoretical basis for clinical treatment of septic shock. Methods Ninety patients with septic shock who were treated in the hospital from February 2013 to February 2015 were selected as study subjects and randomly divided into observation group and control group with 45 cases in each group. Patients in control group were treated with routine infection In the treatment of sexual shock, patients in the observation group were treated with naloxone and Xuebijing in the control group, and the curative effect was compared between the two groups. The data were analyzed by SPSS 16.0 software. Results In 45 cases of observation group, 42 cases were cured, the total effective rate was 93.3%. In 45 cases of control group, 32 cases were cured, the total effective rate was 71.1%. The observation group was obviously superior to the control group. Conclusion Naloxone combined with Xuebijing can effectively improve the condition of patients with septic shock, the treatment effect is significant, can effectively improve the survival rate of patients with septic shock.